Supplementary Table S7: Detailed information of top pathways enriched in non-synonymous Korean only SNVs (SNV-1/ns and SNV-35/ns) | ||||||||||||||||||||||||||||||||||
Korean only SNVs | Order | PathwayName | #Gene | statistics (C: the number of reference genes in the category; O: the number of genes in the gene set and also in the category; E: the expected number in the category; R: ratio of enrichment; rawP: p value from hypergeometric test; adjP: p value adjusted by the multiple test adjustment; ) |
EntrezGene | |||||||||||||||||||||||||||||
SNV-1 | 1 | Metabolic pathways | 295 | C=1130;O=295;E=135.54;R=2.18;rawP=1.34e-39;adjP=2.61e-37 | 2678, 2548, 32, 317749, 4942, 3631, 387787, 116285, 4124 | |||||||||||||||||||||||||||||
2 | ECM-receptor interaction | 47 | C=85;O=47;E=10.20;R=4.61;rawP=8.10e-22;adjP=7.90e-20 | 2335, 3339, 8516, 3655, 10319, 7059, 284217, 3693, 3371, 1293, 131873, 7057, 3914, 3909, 2811, 3696, 1289, 3690, 3913, 1282, 22801, 3672, 960, 3680, 1311, 3910, 3695, 1292, 1290, 7143, 3915, 1286, 1277, 9900, 5649, 3908, 1605, 1101, 3679, 3673, 3912, 7450, 51206, 3691, 1288, 3911, 3381 | ||||||||||||||||||||||||||||||
3 | Focal adhesion | 72 | C=200;O=72;E=23.99;R=3.00;rawP=1.31e-18;adjP=8.52e-17 | 8516, 1793, 5156, 3371, 2317, 131873, 3909, 6464, 1289, 3 | ||||||||||||||||||||||||||||||
4 | Lysosome | 43 | C=121;O=43;E=14.51;R=2.96;rawP=1.67e-11;adjP=8.14e-10 | 2548, 8218, 768239, 256471, 1508, 23163, 4125, 23062, 23457, 8120, 22901, 2588, 50617, 3373, 5641, 1212, 9741, 1511, 51172, 3482, 11154, 6556, 5538, 1510, 6609, 535, 1777, 4891, 26503, 1203, 3988, 4864, 3423, 950, 1497, 10312, 1213, 23659, 2720, 245972, 5660, 411, 3073 | ||||||||||||||||||||||||||||||
5 | Calcium signaling pathway | 53 | C=177;O=53;E=21.23;R=2.50;rawP=1.43e-10;adjP=5.58e-09 | 5724, 196883, 89869, 6261, 489, 5024, 8912, 6543, 5156, 5 | ||||||||||||||||||||||||||||||
6 | Pathways in cancer | 79 | C=326;O=79;E=39.10;R=2.02;rawP=6.36e-10;adjP=2.07e-08 | 2475, 10928, 6256, 7157, 5156, 637, 1441, 23604, 1387, 4193, 3909, 999, 4790, 5336, 1282, 5293, 4233, 5159, 3910, 207, 862, 1630, 1019, 868, 5727, 3908, 2260, 5743, 675, 7185, 8312, 3673, 3912, 8900, 7188, 405, 3911, 4318, 673, 2335, 3728, 3655, 7186, 1495, 10319, 5900, 2113, 284217, 3914, 2737, 4313, 5601, 1612, 3913, 3320, 89780, 6774, 2956, 7423, 613, 5915, 7424, 3915, 1286, 354, 1956, 7175, 8031, 3091, 7849, 3569, 5371, 652, 5337, 1288, 1017, 4843, 6789, 1436 | ||||||||||||||||||||||||||||||
7 | Purine metabolism | 48 | C=162;O=48;E=19.43;R=2.47;rawP=1.52e-09;adjP=4.23e-08 | 196883, 9060, 55276, 5313, 4882, 171568, 9615, 5139, 272 | ||||||||||||||||||||||||||||||
8 | Pancreatic secretion | 35 | C=101;O=35;E=12.11;R=2.89;rawP=2.66e-09;adjP=6.48e-08 | 196883, 489, 8681, 5646, 6344, 1080, 100137049, 1360, 5331, 5644, 115, 109, 112, 64600, 50487, 1131, 1179, 123745, 219931, 107, 6262, 1056, 3784, 3710, 487, 23436, 51032, 1811, 9635, 3708, 5332, 482, 22802, 886, 493 | ||||||||||||||||||||||||||||||
9 | Dilated cardiomyopathy | 32 | C=90;O=32;E=10.80;R=2.96;rawP=6.11e-09;adjP=1.32e-07 | 7273, 196883, 1756, 8516, 3655, 5566, 3693, 3696, 775, 59 | ||||||||||||||||||||||||||||||
10 | Tight junction | 40 | C=132;O=40;E=15.83;R=2.53;rawP=1.68e-08;adjP=3.28e-07 | 4622, 57530, 154810, 8735, 1495, 1457, 4627, 64398, 7082 | ||||||||||||||||||||||||||||||
SNV-35 | 1 | Vibrio cholerae infection | 2 | C=54;O=2;E=0.04;R=55.08;rawP=0.0006;adjP=0.0018 | 4583, 1080 | |||||||||||||||||||||||||||||
2 | Axon guidance | 2 | C=129;O=2;E=0.09;R=23.06;rawP=0.0034;adjP=0.0051 | 6093, 6092 | ||||||||||||||||||||||||||||||
3 | Olfactory transduction | 2 | C=388;O=2;E=0.26;R=7.67;rawP=0.0279;adjP=0.0279 | 256144, 390174 |